[ÇÑÅõÁõ±Ç ÁøÈ«±¹] Á¦¾à/¹ÙÀÌ¿À µ¥Àϸ® ´º½º
¾È³çÇϼ¼¿ä ÇÑÅõÁõ±Ç Á¦¾à¹ÙÀÌ¿À ÁøÈ«±¹ÀÔ´Ï´Ù.
¢º️ÀüÀÏ ¹Ì±¹ ÁÖ¿ä À妽º
* ´Ù¿ì -0.6% S&P Á¦¾à +0.2% ³ª½º´Ú ¹ÙÀÌ¿À -0.8%
¢º️ÇØ¿Ü Peer ÀüÀÏ ÁÖ°¡
* ¼¿Æ®¸®¿Â °ü·Ã: Pfizer +0.4% J&J +0.5% Teva +0.1% Mylan +0.3%
* »ï¼º¹ÙÀÌ¿À °ü·Ã: Lonza +0.5% Merck +0% Roche +0.8% Amgen -1.8% Biogen +0.1%
* Çѹ̾àÇ° °ü·Ã: Sanofi +0% Spectrum -0.7%
* º¸Å彺: Allergan -1.1% Revance Therapeutic -1.3% Evolus -0.8%
* ±âŸ: Gilead Science -0.3% Regeneron -0.7% Abbvie -0.6% Celgene +0.4% Eli Lilly +1% CSL +0.9%
¢º️±¹³» À̽´
* ´ë¿õÁ¦¾à, 'Ú¸ ³ªº¸Å¸ ¼öÃâ' ½ÇÀû¹Ý¿µ º»°Ýȵdzª
* ¿¡º¼·ç½º "³ªº¸Å¸, 3°³¿ù ³» À¯·´Çã°¡...¸¶ÀϽºÅæ 12¾ï"
* º¸·É 'Ä«³ªºê' Çʸ®ÇÉ ·ÐĪ..'µàÄ«ºê' ¸ß½ÃÄÚ Çã°¡
* ¼¿Æ®¸®¿Â ·¥½Ã¸¶ Ú¸ 1Q ¸ÅÃâ 5700¸¸Ý×..Àü³âÝï 5%¡è
* ³ì½ÊÀÚ, ù ¼ºÀûÇ¥ '¶Ò'...ij½ÃÄ«¿ì ¼¼´ë±³Ã¼ ¼ºÀåÅë
* ½Ä¾àó, ¹Ì±¹ ÄÚ¿À·ÕƼ½´Áø ÇöÁö½Ç»ç ÀÏÁ¤ ÇùÀÇÁß
* 4¿ù ¼öÃâ '¹ÙÀÌ¿ÀÇコ¡¤ÀǾàÇ°' ¼±Àü¡¦ 23%¡¤35%¡è
* ´º¶óŬÁ¦³×ƽ½º, 159¾ï È®º¸.."AAV À¯ÀüÀÚÄ¡·áÁ¦ °³¹ß"
* ¿¡½ºÆ¼ÆÊ, È¿¬ 'ÀÎÇ÷翣ÀÚ ½Å¾àÈĺ¸¹°Áú' µµÀÔ
* ¿¹Á¤µÈ °á¸»?¡¦'Å°Æ®·ç´Ù'¿Í '¿Éµðº¸' »çÀüÇù»ó °á·Ä
¢º️ÇØ¿Ü À̽´
* ¹ÙÀ̽ÃŬ Å׶óǻƽ½º, Ú¸ IPO ÅëÇØ 8625¸¸Ý× À¯Ä¡
* ¼Ò¾Æ CÇü °£¿° ÃÖÃÊ ¹üÀ¯ÀüÀÚÇü Ä¡·á´ë¾È È®º¸
* ´ÙÄÉ´Ù, À¯·´¼ ¼º°øº¸¼öÇü Á¦µµ µµÀÔ °ËÅä
* ¾Æ½ºÆ®¶óÁ¦³×Ä«, 1ºÐ±â Ç×¾ÏÁ¦ ¸ÅÃâ 54% ±ÞÁõ
* ¾Öºêºñ, ¡®ÈÞ¹Ì¶ó¡¯ ¿©ÆÄ 1/4ºÐ±â ¸ÅÃâ ¼ÒÆøÇ϶ô
|
°¨»çÇÕ´Ï´Ù
°¨»çÇÕ´Ï´Ù~